33.95
-0.55
(-1.59%)
At close: 1:30:36 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-53,437.00
-69,369.00
-52,891.00
-29,181.00
-62,243.00
Investing Cash Flow
-2,141.00
22,445.00
-1,137.00
-104,820.00
-42,111.00
Financing Cash Flow
-12,251.00
-7,895.00
-13,156.00
-4,162.00
-23,437.00
End Cash Position
104,624.00
133,893.00
189,480.00
255,659.00
394,237.00
Capital Expenditure
-3,808.00
-2,013.00
-1,093.00
-8,430.00
-11,200.00
Repurchase of Capital Stock
--
--
--
--
-8,741.00
Free Cash Flow
-57,245.00
-71,382.00
-53,984.00
-37,611.00
-73,443.00
12/31/2020 - 12/31/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4130.TWO Genovate Biotechnology Co., Ltd.
25.30
+1.81%
3176.TWO Medigen Biotechnology Corp.
32.60
-1.21%
6492.TWO Senhwa Biosciences, Inc.
42.35
+0.47%
4167.TWO Savior Lifetec Corporation
19.75
-0.25%
4133.TW Abnova (Taiwan) Corporation
29.80
-1.16%
4147.TWO TaiMed Biologics Inc.
86.50
+0.35%
6535.TWO Lumosa Therapeutics Co., Ltd.
263.50
-0.57%
6541.TW Tanvex BioPharma, Inc.
65.30
+3.98%
4162.TWO PharmaEngine, Inc.
95.10
+2.15%
4168.TWO GlycoNex Incorporation
24.00
0.00%